Nov 23 2013
The spin-off from Joseph Fourier University, Grenoble (UJF), starts its incubation period accompanied by Grenoble’s innovation accelerators, Gravit and GATE1. Based on research by its leader, Prof. Jean Viallet (Associate Professor at UJF), the team intends to develop very promising in vivo assays for drug development, particularly for cancer treatments
Mar 7
2023
Available online
An IN-VIVO Therapeutic Antibody Efficacy Evaluation
Since its introduction, xenografts on the chicken embryo’s ChorioAllantoic Membrane (CAM) has proven extremely valuable for in vivo studies of tumor development, angiogenesis and malignant cell dissemination. The CAM’s ability to efficiently grow inoculated xenogenic tumor cells greatly simplify the analysis of human tumor cell metastasis. [...]
Feb 22
2023
Join us at the ACE DRUG DISCOVERY SUMMIT in London, March 2 -3 !
Join us at the ACE DRUG DISCOVERY SUMMIT in London, March 2 -3 ! This event provides a platform for scientists, researchers and decision makers from all over the world to discuss the latest scientific […]
Feb 6
2023
Available online
Poster: PD-1/PD-L1 Checkpoint Inhibitors Are Active in the Chicken Embryo Model and Show Antitumor Efficacy In Ovo
Inovotion's IO results: “PD-1/PD-L1 Checkpoint Inhibitors Are Active in the Chicken Embryo Model and Show Antitumor Efficacy In Ovo” [...]
